For decades, genetics has had a frustrating problem:
We can find mutations much faster than we can understand them.
A DNA sequence may differ from the reference genome by a single letter. But what does that one-letter change actually do?
Does it alter gene expression?
Does it disrupt RNA splicing?
Does it affect a regulatory element?
Or does it do nothing at all?
Now AI is beginning to tackle this problem at an entirely different scale.
Google DeepMind has released AlphaGenome Atlas, a massive predictive resource covering roughly 9 billion possible single-nucleotide changes across the human genome.
Instead of simply cataloguing mutations, AlphaGenome attempts to predict their biological consequences — including effects on gene regulation, RNA processing, chromatin accessibility, and other molecular processes.
Think about the shift:
Before:
DNA sequencing → Find a mutation → Study it
Now:
DNA → AI → Predict billions of possible mutations → Prioritize the important ones → Test them experimentally
That changes the economics of biological discovery.
Scientists cannot realistically test billions of mutations one by one.
But an AI model can potentially screen the search space first and tell researchers where to look.
And this may be especially important for rare genetic diseases, where a patient's mutation may sit in a poorly understood region of the genome.
The bigger story isn't simply that AI analyzed a huge amount of DNA.
It's that biology may be moving from:
“What mutations exist?”
to
“What would happen if every possible mutation occurred?”
That is a fundamentally different question.
AlphaFold helped make protein structures computationally searchable.
AlphaGenome is pushing toward something potentially broader:
making the functional consequences of DNA variation searchable.
Of course, predictions are not experiments. A model can generate hypotheses, but biology still has the final vote.
Yet if AI can predict the effects of billions of genetic changes before scientists test them…